Last reviewed · How we verify
Luitpold Azacitidine
At a glance
| Generic name | Luitpold Azacitidine |
|---|---|
| Also known as | Single use vials containing 100 mg azacitidine/vials,.The formulation contained mannitol as an excipient. Lot 090035 and Lot 120011 |
| Sponsor | American Regent, Inc. |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Luitpold Azacitidine CI brief — competitive landscape report
- Luitpold Azacitidine updates RSS · CI watch RSS
- American Regent, Inc. portfolio CI